Effect of anti-inflammatory medication on monocyte response to titanium particles
- 21 September 2000
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 52 (3), 509-516
- https://doi.org/10.1002/1097-4636(20001205)52:3<509::aid-jbm9>3.0.co;2-p
Abstract
Cytokines produced by macrophages in the periprosthetic membranes surrounding joint replacements have been implicated as causal agents in osteolysis and prosthetic loosening. The present study characterizes the response of human peripheral blood monocytes to titanium particles. Monocytes were obtained from donated blood and were cultured in the presence of different‐sized titanium particles. Exposure to titanium‐aluminum‐vanadium particles significantly changed the release of tumor necrosis factor‐α (TNF‐α), interleukin‐6 (IL‐6), and interleukin‐1 (IL‐1), whereas there was no significant effect on the release of prostaglandin E2 (PGE2). When monocytes were cultured with particles, the titanium alloy particles induced significantly more release of TNF‐α and less IL‐1 secretion. Ciprofloxacin inhibited production of TNF‐α, IL‐6, IL‐1, and PGE2 in human monocytes exposed to titanium particles. In contrast to ciprofloxacin, indomethacin was not a potent inhibitor of TNF‐α production but potentiated IL‐6 production in titanium‐stimulated monocytes. Indomethacin had no effect on the production of IL‐1 and was a potent inhibitor of PGE2 production in titanium‐stimulated monocytes. Pentoxifylline had an inhibitor effect on TNF‐α production in titanium‐stimulated monocytes. Pentoxifylline potentiated IL‐6 and IL‐1 production in monocytes exposed to titanium particles and had a biphasic effect on the PGE2 production. The results of this study support our hypothesis that human monocytes release bone resorption mediators after in vitro exposure to TiAlV alloy particles. The results also demonstrate the differences of bone‐resorbing mediators in response to different wear particle size. The pharmacologic agents (ciprofloxacin, pentoxifylline, and indomethacin) that can modulate the release of bone resorbing mediators such as PGE2, TNF‐α, IL‐1, and IL‐6 release from human monocytes. The results help to elucidate the differences in cellular response to wear particles but may not be directly transposed to the human situation. © 2000 John Wiley & Sons, Inc. J Biomed Mater Res, 52, 509–516, 2000.This publication has 22 references indexed in Scilit:
- Polyethylene wear in knee arthroplastyActa Orthopaedica, 1992
- Macrophage exposure to polymethyl methacrylate leads to mediator release and injuryJournal of Orthopaedic Research, 1991
- The Pathogenesis of Loosening of Total Hip ArthroplastiesClinical Orthopaedics and Related Research, 1990
- The Synovial Response to Intraarticular Cobalt-Chrome Wear ParticlesClinical Orthopaedics and Related Research, 1988
- Foreign Body Reaction to Polymeric Debris Following Total Hip ArthroplastyClinical Orthopaedics and Related Research, 1987
- Formation of a synovial‐like membrane at the bone‐cement interface: Its role in bone resorption and implant loosening after total hip replacementArthritis & Rheumatism, 1986
- The biological response to titanium and titanium-aluminium-vanadium alloy particlesBiomaterials, 1986
- The biological response to titanium and titanium-aluminium-vanadium alloy particlesBiomaterials, 1985
- EFFECTS OF COBALT‐CHROME ALLOY WEAR PARTICLES ON THE MORPHOLOGY, VIABILITY AND PHAGOCYTIC ACTIVITY OF MURINE MACROPHAGES IN VITROImmunology & Cell Biology, 1983
- The production and biology of polyethylene wear debrisArchives of orthopaedic and trauma surgery, 1978